Gram-negative Bacteria, Percentage Resistance | Gram-positive Bacteria, Percentage Resistance | |||||||
---|---|---|---|---|---|---|---|---|
Variables | Escherichia coli | Klebsiella pneumoniae | Acinetobacter baumannii | Variables | Staphylococcus aureus | Staphylococcus coagulase-negative | ||
ESBL+ | ESBL− | ESBL+ | ESBL− | |||||
n | 30 | 36 | 7 | 17 | 36 | n | 30 | 36 |
Antibiotic | Antibiotic | |||||||
Imipenem | 0 | 0 | 0 | 0 | 13.9 | Vancomycin | 0 | 0 |
Ertapenem | 0 | 0 | 0 | 0 | 22.2 | Linezolid | 0 | 0 |
Amikacin | 33.3 | 22.2 | 42.9 | 23.5 | 33.3 | Rifampicin | 6.7 | 8.3 |
Gentamicin | 90.0 | 58.3 | 71.4 | 29.4 | 65.6 | Amikacin | 23.3 | 11.1 |
Ceftazidime | 13.3 | 5.6 | 14.3 | 5.9 | 27.8 | Gentamicin | 73.3 | 25.0 |
Ceftriaxon | 43.3 | 11.2 | 42.9 | 11.8 | 100 | Levofloxacin | 26.7 | 47.2 |
Cefepime | 12.2 | 11.2 | 14.3 | 5.9 | 80.6 | Ciprofloxacin | 26.7 | 41.7 |
Aztreonam | 26.7 | 11.2 | 57.1 | 29.4 | — | Clindamycin | 30.0 | 30.6 |
Levofloxacin | 53.3 | 16.7 | 14.3 | 5.9 | 44.4 | Oxacillin | 100.0 | 100.0 |
Ciprofloxacin | 56.7 | 52.8 | 57.1 | 47.1 | 66.7 | Erythromycin | 73.3 | 75.0 |
Ampicillin | 100.0 | 80.6 | 71.4 | 58.9 | 100 | Penicillin | 96.7 | 88.9 |
Piperacillin/tazobactam | 3.3 | 2.8 | 0 | 0 | 27.8 | |||
Cefoperazone/sulbactam | 13.3 | 8.3 | 14.3 | 5.9 | 11.1 | |||
Amoxicillin/clavulanic | 73.3 | 52.8 | 57.1 | 23.6 | — | |||
Sulfamethoxazole trimethoprim | 63.3 | 66.7 | 57.2 | 52.9 | — | |||
Colistin | 0 | 0 | 0 | 0 | 0 |
ESBL: extended-spectrum β-lactamase.